Substance use disorders in individuals with mild to borderline intellectual disability: Current status and future directions

Research in Developmental Disabilities

Volumn 38, Issue , 2015, Pages 319-328

  van Duijvenbode, Neomi ^a   VanDerNagel, Joanneke E L ^a,b   Didden, Robert ^a,b   Engels, Rutger C M E ^a,c   Buitelaar, Jan K ^d   Kiewik, Marion ^a,b   de Jong, Cor A J ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b Aveleijn ^*  (Netherlands)

^c NETHERLANDS INSTITUTE OF MENTAL HEALTH AND ADDICTION   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Assessment; Intellectual disability; Prevalence; Screening; Substance use disorder; Treatment

Indexed keywords

HUMAN; INTELLECTUAL DISABILITY; MASS SCREENING; PREVALENCE; PROCEDURES; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

HUMANS; INTELLECTUAL DISABILITY; MASS SCREENING; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS;

EID: 84920901879     PISSN: 08914222     EISSN: 18733379     Source Type: Journal    
DOI: 10.1016/j.ridd.2014.12.029     Document Type: Review

References (86)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2013, American Psychiatric Association, Washington, DC. 5th ed.
2. Babor T.F., Higgins-Biddle J.C., Saunders J.B., Monteiro M.G. AUDIT. The alcohol use disorders identification test: Guidelines for use in primary care 2001, World Health Organisation, Geneva. 2nd ed.
3. Bailey G.L., Herman D.S., Stein M.D. Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification. Journal of Substance Abuse Treatment 2013, 45:302-305.
4. Bechara A., Noel X., Crone E.A. Loss of willpower: Abnormal neural mechanisms of impulse control and decision making in addiction. Handbook of implicit cognition and addiction 2006, 215-233. Sage Publications, Thousand Oaks, CA. R.W. Wiers, A.W. Stacy (Eds.).
5. Berman A.H., Bergman H., Palmstierna T., Schlyter F. DUDIT. The drug use disorders identification test manual 2003, Karolinska Institutet, Department of Clinical Neuroscience, Stockholm.
6. Burgard J.F., Donohue B., Azrin N.H., Teichner G. Prevalence and treatment of substance abuse in the mentally retarded population: An empirical review. Journal of Psychoactive Drugs 2000, 32:293-298.
7. Carroll Chapman S.L., Wu L.-T. Substance abuse among individuals with intellectual disability. Research in Developmental Disabilities 2012, 33:1147-1156.
8. Center for Substance Abuse Treatment The epidemiology of co-occurring substance use and mental disorders. COCE overview paper 8 2007, Substance Abuse and Mental Health Services Administration, and Center for Mental Health Services, Rockville, MD.
9. Chaplin E., Gilvarry C., Tsakanikos E. Recreational substance use patterns and co-morbid psychopathology in adults with intellectual disability. Research in Developmental Disabilities 2011, 32:2981-2986.
10. Collins S.E., Clifasefi S.L., Logan D.E., Samples L.S., Somers J.M., Marlatt G.A. Current status, historical highlights, and basic principles of harm reduction. Harm reduction. Pragmatic strategies for managing high-risk behaviors 2012, 3-35. The Guilford Press, New York, NY. G.A. Marlatt, M.E. Larimer, K. Witkiewitz (Eds.).
11. Connors G.J., Maisto S.A. Drinking reports from collateral individuals. Addiction 2003, 98(Suppl. 2):21-29.
12. Conrod P., Pihl R., Stewart S., Dongier M. Validation of a system of classifying female substance abusers on the basis of personality and motivational risk factors for substance abuse. Psychology of Addictive Behaviors 2000, 14:243-256.
13. Cooper S.A., Smiley E., Morrison J., Williamson A., Allen L. Mental ill-health in adults with intellectual disabilities: Prevalence and associated factors. British Journal of Psychiatry 2007, 190:27-35.
14. Dackis C., O'Brien C. Neurobiology of addiction: Treatment and public policy ramifications. Nature Neuroscience 2005, 8:1431-1436.
15. Degenhardt L. Interventions for people with alcohol use disorders and an intellectual disability: A review of the literature. Journal of Intellectual and Developmental Disabilities 2000, 25:135-146.
16. Dennis M.L., Foss M.A., Scott C.K. An 8-year perspective on the relationship between the duration of abstinence and other aspects of recovery. Evaluation Review 2007, 31:585-612.
17. Dennis M.L., Scott C.K. Managing addiction as a chronic condition. Addiction Science and Clinical Practice 2007, 4:45-55.
18. Didden R., Embregts P., Van der Toorn M., Laarhoven N. Substance abuse, coping strategies, adaptive skills and behavioral and emotional problems in clients with mild to borderline intellectual disability admitted to a treatment facility: A pilot study. Research in Developmental Disabilities 2009, 30:927-932.
19. Donovan D.M. Assessment of addictive behaviors for relapse prevention. Assessment of addictive behaviors 2005, 1-48. The Guilford Press, New York, NY. 2nd ed. D.M. Donovan, G.A. Marlatt (Eds.).
20. Field M., Cox W.M. Attentional bias in addictive behaviors: A review of its development, causes, and consequences. Drug and Alcohol Dependence 2008, 97:1-20.
21. Finlay W.M.L., Lyons E. Methodological issues in interviewing and using self-report questionnaires with people with intellectual disability. Psychological Assessment 2001, 13:319-335.
22. French M.T., Salomé H.J., Krupski A., McKay J.R., Donovan D.M., McLellan A.T., et al. Benefit-cost analysis of residential and outpatient addiction treatment in the state of Washington. Evaluation Review 2000, 24:609-634.
23. Frielink N., Embregts P. Modification of motivational interviewing for use with people with mild intellectual disability and challenging behaviour. Journal of Intellectual and Developmental Disability 2013, 38:279-291.
24. Garavan H., Brennan K.L., Hester R., Whelan R. The neurobiology of successful abstinence. Current Opinion in Neurobiology 2013, 23:668-674.
25. Gerard M., Gibbons F.X., Houlihan A.E., Stock M.L., Promery E.A. A dual-process approach to health risk decision making: The prototype willingness model. Developmental Review 2008, 28:29-61.
26. Godley M.D., Godley S.H., Dennis M.L., Funk R.R., Passetti L.L. The effect of assertive continuing care (ACC) on continuing care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders. Addiction 2007, 102:81-93.
27. Hassiotis A., Gazizova D., Akinlonu L., Bebbington P., Meltzer H., Strydom A. Psychiatric morbidity in prisoners with intellectual disabilities: Analysis of prison survey data for England and Wales. British Journal of Psychiatry 2011, 1999:156-157.
28. Heal L.W., Sigelman C.K. Response biases in interviews of individuals with limited mental ability. Journal of Intellectual Disability Research 1995, 39:331-340.
29. Horsfall J., Cleary M., Hunt G.E., Walter G. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): A review of empirical evidence. Harvard Review of Psychiatry 2009, 17:24-34.
30. Hyman S.E. Addiction: A disease of learning and memory. American Journal of Psychiatry 2005, 162:1414-1422.
31. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: The role of reward-related learning and memory. Annual Review of Neuroscience 2006, 29:565-598.
32. Johanson C.-E., Frey K.A., Lundahl L.H., Keenan P., Lockhart N., Roll J., et al. Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers. Psychopharmacology 2005, 185:327-338.
33. Kelman L.V., Lindsay W.R., McPherson F.M., Mathewson Z. Smoking education for people with learning disabilities. British Journal of Learning Disabilities 1997, 25:95-99.
34. Kerr S., Lawrence M., Darbyshire C., Middleton A.R., Fitzsimmons L. Tobacco and alcohol-related interventions for people with mild/moderate intellectual disabilities: A systematic review of the literature. Journal of Intellectual Disability Research 2013, 57:393-408.
35. Kessler R.C. The epidemiology of dual diagnosis. Biological Psychiatry 2004, 56:730-737.
36. Koob G.F. Addiction is a reward deficit and stress surfeit disorder. Frontiers in Psychiatry 2013, 4:1-18.
37. Lindsay W.R., Carson D., Holland A.J., Taylor J.L., O'Brien G., Wheeler J.R., et al. Alcohol and its relationship to offence variables in a cohort of offenders with intellectual disability. Journal of Intellectual and Developmental Disability 2013, 38:325-331.
38. Lindsay W.R., McPherson F.M., Kelman L.V., Mathewson Z. Health promotion and people with learning disabilities: The design and evaluation of three programmes. Health Bulletin 1998, 56:694-698.
39. MacLeod C.M., Mathews A., Tata P. Attentional bias in emotional disorders. Journal of Abnormal Psychology 1986, 95:15-20.
40. Marlatt G.A., Witkiewitz K. Relapse prevention for alcohol and drug problems. Relapse prevention. Maintenance strategies in the treatment of addictive behaviors 2005, 1-44. The Guilford Press, New York, NY. G.A. Marlatt, D.M. Donovan (Eds.).
41. Mayfield D., McLeod G., Hall P. The CAGE questionnaire: Validation of a new alcoholism screening instrument. American Journal of Psychiatry 1974, 131:1121-1123.
42. McGillicuddy N.B. A review of substance use research among those with mental retardation. Mental Retardation and Developmental Disabilities Research Reviews 2006, 12:41-47.
43. McGillicuddy N.B., Blane H.T. Substance use in individuals with mental retardation. Addictive Behaviors 1999, 24:869-878.
44. McLaughlin D.F., Taggart L., Quinn B., Milligan V. The experiences of professionals who care for people with intellectual disability who have substance-related problems. Journal of Substance Use 2007, 12:133-143.
45. McLellan A.T., Lewis D.C., O'Brien C.P., Kleber H.D. Drug dependence, a chronic medical illness. Implications for treatment, insurance, and outcomes evaluation. Journal of the American Medical Association 2000, 284:1689-1695.
46. McLellan A.T., McKay J.R., Forman R., Cacciola J., Kemp J. Reconsidering the evaluation of addiction treatment: From retrospective follow-up to concurrent recovery monitoring. Addiction 2005, 100:447-458.
47. Mental Health Special Interest Group Mental health and intellectual disabilities. Addressing the mental health needs of people with intellectual disabilities 2001, Retrieved from http://iassid.org/pdf/mh-sirg-who-final.pdf.
48. Merikangas K.R., McClair V.L. Epidemiology of substance use disorders. Human Genetics 2012, 131:779-789.
49. Mertens J.R., Lu Y.W., Parthasarathy S., Moore C., Weisner C.M. Medical and psychiatric conditions of alcohol and drug treatment patients in an HMO comparison with matched controls. Archives of Internal Medicine 2003, 163:2511-2517.
50. Moore D., Lorber C. Clinical characteristics and staff training needs of two substance use disorder treatment programs specialized for persons with disabilities. Journal of Teaching in the Addictions 2004, 3:3-20.
51. National Institute on Drug Abuse Principles of drug addiction treatment. A research-based guide 2012, National Institute on Drug Abuse, Rockville, MD. 3rd ed.
52. Nestler E.J. Is there a common molecular pathway for addiction?. Nature Neuroscience 2005, 8:1445-1449.
53. O'Brien C.P., Charney D.S., Lewis L., Cornish J.W., Post R.M., Woody G.E., et al. Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: A call to action. Biological Psychiatry 2004, 56:703-713.
54. Petry N.M. Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics and controls. Psychopharmacology 2001, 154:243-250.
55. Reif S., George P., Braude L., Dougherty R.H., Daniels A.S., Ghose S.S., et al. Residential treatment for individuals with substance use disorders: Assessing the evidence. Psychiatric Services 2014, 65:301-312.
56. Rinck M., Becker E.S. Approach and avoidance in fear of spiders. Journal of Behavioral Therapy and Experimental Psychiatry 2007, 38:105-120.
57. Robinson T.E., Berridge K.C. Addiction. Annual Review of Psychology 2003, 54:25-53.
58. Robinson T.E., Berridge K.C. The incentive sensitization theory of addiction: Some current issues. Philosophical Transaction of the Royal Society of London: Series B. Biological Sciences 2008, 363:3137-3146.
59. Sannibale C., Hurkett P., van der Bossche E., O'Connor D., Zador D., Capus C., et al. Aftercare attendance and post-treatment functioning of severely substance dependent residential treatment clients. Drug and Alcohol Review 2003, 22:181-190.
60. Selzer M.L. The Michigan alcoholism screening test: The quest for a new diagnostic instrument. American Journal of Psychiatry 1971, 127:1653-1658.
61. Shapiro B., Coffa D., McCance-Katz E.F. A primary care approach to substance misuse. American Family Physician 2013, 88:113-121.
62. Simpson M. Alcohol and intellectual disability: Personal problem or cultural exclusion?. Journal of Intellectual Disability Research 2012, 16:183-192.
63. Slayter E.M. Understanding and overcoming barriers to substance abuse treatment access for people with mental retardation. Journal of Social Work in Disability and Rehabilitation 2008, 7:63-80.
64. Slayter E.M. Demographic and clinical characteristics of people with intellectual disabilities with and without substance abuse disorders in a Medicaid population. Intellectual and Developmental Disabilities 2010, 48:417-431.
65. Slayter E.M. Adults with dual eligibility for Medicaid and Medicare: Access to substance abuse treatment. Journal of Social Work in Disability and Rehabilitation 2011, 10:67-81.
66. Stacy A.W., Wiers R.W. Implicit cognition and addiction: A tool for explaining paradoxical behavior. Annual Review of Clinical Psychology 2010, 6:551-575.
67. Sterling S., Chi F., Hinman A. Integrating care for people with co-occurring alcohol and other drug, medical, and mental health conditions. Alcohol Research & Health 2011, 33:338-349.
68. Sturmey P., Reyer H., Lee R., Robek A. Substance-related disorders in persons with mental retardation 2003, NADD Press, Kingston.
69. Swendsen J., Burstein M., Case B., Conway K.P., Dierker L., He J., et al. Use and abuse of alcohol and illicit drugs in US adolescents: Results of the National Comorbidity Survey - Adolescent Supplement. Archives of General Psychiatry 2012, 69:390-398.
70. To W.T., Neirynck S., Vanderplasschen W., Vanheule S., Vandevelde S. Substance use and misuse in persons with intellectual disabilities (ID): Results of a survey in ID and addiction services in Flanders. Research in Developmental Disabilities 2014, 35:1-9.
71. VanDerNagel J.E.L., De Jong C.A.J. ZonMW Dossier number: 31160202 (SumID project) final report data 2012, Tactus, Deventer, The Netherlands.
72. VanDerNagel J.E.L., Kemna L.E.M., Didden R. Substance use among persons with mild intellectual disability: Approaches to screening and interviewing. NADD Bulletin 2013, 16:87-92.
73. VanDerNagel J.E.L., Kiewik M., Buitelaar J.K., De Jong C.A.J. Staff perspectives of substance use and misuse among adults with intellectual disabilities enrolled in Dutch disability services. Journal of Policy and Practice in Intellectual Disabilities 2011, 8:143-149.
74. VanDerNagel J.E.L., Kiewik M., Van Dijk M., De Jong C.A.J., Didden R. Handleiding SumID-Q, Meetinstrument voor het in kaart brengen van Middelengebruik bij mensen met een lichte verstandelijke beperking 2011, Tactus, Deventer, The Netherlands.
75. VanDerNagel J.E.L., Kiewik M., Postel M.G., Van Dijk M., Didden R., Buitelaar J.K., et al. Capture recapture estimation of the prevalence of mild intellectual disability and substance use disorder. Research in Developmental Disabilities 2014, 35:808-813.
76. Van den Brink W. Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Current Drug Abuse Reviews 2012, 5:3-31.
77. Van Duijvenbode N., Didden R., Bloemsaat G., Engels R.C.M.E. Problematic alcohol use and mild intellectual disability: Standardization of pictorial stimuli. Research in Developmental Disabilities 2012, 33:1095-1102.
78. Van Duijvenbode N., Didden R., Korzilius H.P.L.M., Trentelman M., Engels R.C.M.E. Executive control in long-term abstinent alcoholics with mild to borderline intellectual disability: The relationship with IQ and severity of alcohol use-related problems. Research in Developmental Disabilities 2013, 34:3583-3595.
79. Van Duijvenbode N., Didden R., Voogd H., Korzilius H.P.L.M., Engels R.C.M.E. Cognitive biases in individuals with mild to borderline intellectual disability and alcohol use-related problems. Research in Developmental Disabilities 2012, 33:1928-1936.
80. Verdejo-García A., Lawrence A.J., Clark L. Impulsivity as a vulnerability marker for substance-use disorders: Review of findings from high-risk research, problem gamblers and genetic association studies. Neuroscience and Biobehavioral Reviews 2008, 32:777-810.
81. Volkow N.D., Wang G.-J., Tomasi D., Baler R.D. Unbalanced neuronal circuits in addiction. Current Opinion in Neurobiology 2013, 23:639-648.
82. White W., Boyle M., Loveland D. Addiction as chronic disease: From rhetoric to clinical application. Alcoholism Treatment Quarterly 2003, 3(4):107-130.
83. Wiers R.W., Bartholow B.D., Van den Wildenberg E., Thush C., Engels R.C.M.E., Sher K.J., et al. Automatic and controlled processes and the development of addictive behaviors in adolescents: A review and a model. Pharmacology, Biochemistry and Behavior 2007, 86:263-283.
84. Wiers R.W., Gladwin T.E., Hofman W., Salemink E., Ridderinkhof K.R. Cognitive bias modification and cognitive control training in addiction and related psychopathology: Mechanisms, clinical perspectives, and ways forward. Clinical Psychological Science 2013, 1:192-212.
85. Wilson C.R., Sherritt L., Gates E., Knight J.R. Are clinical impressions of adolescent substance use accurate?. Pediatrics 2004, 114:536-540.
86. Wong C.C., Schumann G. Genetics of addictions: Strategies for addressing heterogeneity and polygenicity of substance use disorder. Philosophical Transactions of the Royal Society of London. Series B. Biological Sciences 2008, 363:3213-3222.